Desprescribing antihypertensives in older people in primary care: subgroup analysis of the MINOR randomised clinical trial
- 6 November 2024
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 47 (1) , 53-59
Abstract
Background Polypharmacy is often required for older adults with hypertension, and excessive treatment is associated with a high risk of adverse reactions, including hypotension. Aim To evaluate the deprescribing of antihypertensive medications guided by pharmacists using home blood pressure monitoring in older adults with hypotension. Method A subgroup of older adults with signs or symptoms of hypotension, included in the MINOR clinical trial, was analysed. In the MINOR procedures, each patient was provided with a device to conduct blood pressure measurement at home for 1 week, following which a report was generated and shared with pharmacists (intervention group) or family physicians (control group). In the intervention group, a pharmacist suggested optimising pharmacotherapy; meanwhile, in the control group, a family physician alone determined the necessary treatment adjustments. Differences in mean blood pressure, the patients with symptoms/signs of hypotension, and the antihypertensive medication deprescribing between both groups were analysed. Results Seventy-two patients were evaluated (35, control group; 37, intervention group). The intervention group showed a significant reduction in medication prescriptions (− 28.6%; P < 0.001), especially beta-blockers (− 74.2%), loop diuretics (− 83.3%), and aldosterone antagonists (− 80%). The mean office blood pressure in the intervention group increased (14.1 mmHg systolic and 6.9 mmHg diastolic), remaining below the target range (140/90 mmHg). The intervention group showed a significantly reduction in hypotensive symptoms than the control group (64.9% vs. 20%) (P < 0.001). Conclusion The data highlight an important role for pharmacists in optimizing hypertension management in older people. Deprescribing antihypertensives can limit symptomatic hypotension. Trial Registration Registered on ClinicalTrials.gov under number NCT04861727.Keywords
Funding Information
- CAPES
- CNPq
- Universidade Federal da Bahia
This publication has 30 references indexed in Scilit:
- Optimizing Hypertension Treatment in Older Patients Through Home Blood Pressure Monitoring by Pharmacists in Primary Care: The MINOR Clinical TrialClinical Therapeutics, 2023
- Implementation of pharmacist-led deprescribing in collaborative primary care settingsInternational Journal of Clinical Pharmacy, 2022
- Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre monitorización ambulatoria de la presión arterial (MAPA) 2019Hipertensión y Riesgo Vascular, 2019
- Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older PatientsDrugs & Aging, 2019
- International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for ActionDrugs & Aging, 2018
- Beta-blockers for hypertensionCochrane Database of Systematic Reviews, 2017
- Treatment With Multiple Blood Pressure Medications, Achieved Blood Pressure, and Mortality in Older Nursing Home ResidentsJAMA Internal Medicine, 2015
- Evaluation of Multidimensional Geriatric Assessment as a Predictor of Mortality and Cardiovascular Events After Transcatheter Aortic Valve ImplantationJACC: Cardiovascular Interventions, 2012
- Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndromeAutonomic Neuroscience, 2011
- Cardiovascular Protection Using Beta-BlockersJACC, 2007